Franz Von Koch, MD

Articles by Franz Von Koch, MD

Dose-Dense and Sequential Strategies in Adjuvant Breast Cancer Therapy

ByMichael Untch, MD, PhD,Franz Von Koch, MD,C. Crohns, MD,K. Sobotta, MD,Steffen Kahlert, MD,Gottfried E. Konecny, MD,H. Hepp, MD

May 1st 2001

Several attempts have been made to improve the survival rates of breast cancer patients. The benefit of adjuvant chemotherapy was clearly shown, but the absolute difference of 2% to 11% in overall survival, depending on the

Latest Updated Articles

Dose-Dense and Sequential Strategies in Adjuvant Breast Cancer Therapy
May 1st 2001

Franz Von Koch, MD

Articles by Franz Von Koch, MD

Dose-Dense and Sequential Strategies in Adjuvant Breast Cancer Therapy

Latest Updated Articles

Trending on CancerNetwork

MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer

Selecting Among Preferred 1L Regimens — A Discussion

What is the Future of TIL Therapy in Metastatic Melanoma?

Clinical Context & MARIPOSA Efficacy in 1L EGFRm NSCLC

Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors